Position in LLY
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$4,654,843,757
-$862,215,679 QoQ
Shares Held
5,060,878
-1.4% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
3.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JENNISON ASSOCIATES LLC holds $5,990,626,556 across 6 Drug Manufacturers - General names. LLY ranks #1 (77.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,060,878 | $4,654,843,757 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,249,337 | $751,732,746 | |
| 3 | ABBV |
AbbVie Inc.
|
1,062,732 | $231,133,582 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,264,546 | $176,239,776 | |
| 5 | AZN |
Astrazeneca PLC
|
663,945 | $130,943,232 | |
| 6 | AMGN |
Amgen Inc
|
129,980 | $45,733,463 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,654,843,757 | 5,060,878 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $5,517,059,436 | 5,133,676 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $3,201,908,136 | 4,196,472 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $4,246,595,690 | 5,447,636 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $4,312,089,324 | 5,221,016 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $3,702,761,356 | 4,796,323 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $6,154,975,126 | 6,947,395 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $6,548,602,675 | 7,232,988 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $5,808,639,895 | 7,466,502 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $4,428,799,986 | 7,597,612 | Shares | Defined | 2024-02-01 | |
| 2023-09-30 | $4,515,981,170 | 8,407,613 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $4,024,522,792 | 8,581,438 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $2,944,539,400 | 8,574,164 | Shares | Defined | 2023-04-26 | |
| 2022-12-31 | $3,815,374,992 | 10,429,081 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $3,254,434,325 | 10,064,742 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $3,358,395,738 | 10,358,066 | Shares | Defined | 2022-08-02 | |
| 2022-03-31 | $2,262,696,998 | 7,901,306 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,528,963,698 | 9,155,614 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,279,196,421 | 9,864,516 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $2,045,251,572 | 8,910,995 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,016,326,394 | 5,440,137 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $317,223,852 | 1,878,843 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $678,031,216 | 4,580,673 | Shares | Defined | 2020-11-04 | |
| 2020-06-30 | $1,323,844,414 | 8,063,372 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $1,413,841,453 | 10,192,052 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||